There’s been a growing interest in this product ever since it was introduced. And it’s no wonder. LATISSE® is the first FDA-approved prescription treatment for inadequate or not enough eyelashes, growing them longer, fuller and darker.
Discover the LATISSE® difference
LATISSE® solution is a growth treatment for hypotrichosis (inadequate or not enough eyelashes). In fact, it’s the first FDA-approved treatment clinically proven to grow lashes. And it’s the first lash growth product of its kind available by prescription, so you’ll need to talk schedule an appointment to see if it’s right for you.
LATISSE® grows lashes longer, fuller and darker
LATISSE® solution is a once-nightly treatment you apply topically to the base of your upper eyelashes. Gradually, you may start to see more length in as little as 4 weeks and you should achieve full growth in 16 weeks. It’s not an illusion of growth. It’s real lash growth.
How LATISSE® works
LATISSE® makes lash growth possible because of its active ingredient: bimatoprost. Although the precise mechanism of action is unknown, LATISSE® is believed to affect the growth (anagen) phase of the eyelash hair cycle in two ways: first, it increases the length of this phase, and second, it increases the number of hairs in this growth phase.
The history behind LATISSE®
LATISSE® was created by Allergan. In 2001, Allergan developed a medicated eye drop to treat elevated intraocular pressure. Many patients using this medication also began to grow longer, fuller and darker lashes as a side effect. This led Allergan to study the medication’s active ingredient, bimatoprost, specifically for growing lashes. After a clinical trial, LATISSE® was approved by the FDA in December of 2008.
Latisse is a participating product for Brilliant Distinctions. Earn and redeem points for savings on your treatments.